Health is Fluid Webinar Series

Webinar Series_Landing Page-3

 

Transforming Cancer Care with Bioimpedance Spectroscopy Technology

A single SOZO® reading allows clinicians across multiple specialties to provide individualised proactive care that can help improve patient outcomes. In this webinar series, leading clinicians and experts discuss the innovation and science behind bioimpedance spectroscopy and how the technology can transform the assessment and management of conditions like cancer-related lymphoedema. We welcome you to join us in this series of informative online presentations followed by live expert Q&A.

SOZO® Science: Understanding Bioimpedance Spectroscopy

Monday, 4 May 2020 | 7:30 - 8:30PM AEST

Presenters: Richelle Gaw, PhD Bioimpedance Spectroscopy, Project Engineer | Leigh Ward, PhD, The University of Queensland, School of Chemistry of Molecular Biosciences 

How can Bioimpedance Spectroscopy aid clinicians in the assessment of chronic disease? Join us for a live webinar and Q&A session where we will discuss the science behind SOZO BIS technology and how it provides a precise snapshot of fluid status and tissue composition in less than 30 seconds.

 

Missed the live webinar? Watch the recorded sessions now by clicking on the linked presentations.

What is Bioimpedance Spectroscopy? | Richelle Gaw BEng(Hons), PhD, Project Engineer, ImpediMed Limited

Now You Can Measure Resistance: So What? | Dr. Leigh Ward, School of Chemistry and Molecular Biosciences, The University of Queensland

 

 

SOZO® with L-Dex®: Clinical Evidence and Preventing Lymphoedema

Monday, 18 May 2020 | 7:30 - 8:30PM AEST

Presenters: Dr. Elizabeth Dylke | Catherine Kingsford  

Subclinical detection of lymphoedema can optimise patient outcomes. Findings from PREVENT1, the largest randomised controlled trial focusing on breast cancer-related lymphoedema prevention will be explored in this webinar session. Learn how a 95% reduction in lymphoedema progression is possible by using early detection with L-Dex, combined with at-home intervention.

 

Missed the live webinar? Watch the recorded sessions now by clicking on the linked presentations.

SOZO with L-Dex Clinical Evidence and Preventing Lymphoedema Part 1 | Dr. Elizabeth Dylke, University of Sydney

SOZO with L-Dex Clinical Evidence and Preventing Lymphoedema Part 2 | Catherine Kingsford, Sr. Vice President Medical Affairs, Impedimed

 

 

 

Lymphoedema Prevention: The Clinically Proven Model of Care

Monday, 1 June 2020 | 7:30 - 8:30PM AEST

Presenters: Louise Koelmeyer | Joann Yao  

Studies show that 1 in 3 cancer survivors will develop lymphoedema.2 The good news is that prevention is possible. By implementing a clinically researched model of preventative care, healthcare professionals can help patients avoid lymphoedema progression and lifelong complications. Join us as we explore how L-Dex can aid with early detection.

 

Missed the live webinar? Watch the recorded sessions now by clicking on the linked presentations.

Together, We Can End Cancer-Related Lymphoedema | Joann Yao, Sr. Director of Marketing, ImpediMed

Early Intervention Model of Care for Breast Cancer Rehabilitation | Louise Koelmeyer, Lymphoedema Program Manager & Senior Lecturer, ALERT program at Macquarie University

 

 

SOZO® with L-Dex® for Unilateral Lymphoedema

Monday, 15 June 2020 | 7:30 - 8:30PM AEST

Presenters: Richelle Gaw | Jen Mckenzie | Dr. Lisa Creighton | Kate Perkins

Managing secondary unilateral lymphoedema in patients poses a significant challenge to healthcare professionals. Join us as we dive into the complication of the condition and explore how SOZO with L-DEX can aid in the assessment and ongoing preventative care for patients.

 

Missed the live webinar? Watch the recorded sessions now by clicking on the linked presentations.

Understanding Unilateral L-Dex | Richelle Gaw, BEng(Hons), PhD, Project Engineer, ImpediMed Limited

The Importance of a Pre-Treatment Baseline with L-Dex Part1 | Jen McKenzie Lymphoedema Physiotherapist and ESSA Accredited Exercise Physiologist

The Importance of a Pre-Treatment Baseline with L-Dex Part2 | Kate Perkins, B.App.Sci (OT), Lymphedema Occupational Therapist

Why I Refer Patients for Pre-Treatment Baseline with L-Dex | Dr. Lisa Creighton, Oncoplastic Breast Surgeon

 

 

 

 

SOZO® with L-Dex® for Bilateral Lymphoedema

Monday, 29 June 2020 | 7:30 - 8:30PM AEST

Presenters: Richelle Gaw | Maree O'Conner

With L-Dex®, bilateral lymphedema assessment is possible and clinically proven to be accurate. Join our experts in this informative webinar where we will focus on how SOZO technology can help healthcare professionals monitor fluid status for bilateral lymphoedema.

 

Missed the live webinar? Watch the recorded sessions now by clicking on the linked presentations.

Understand Bilateral Lymphedema | Richelle Gaw, BEng(Hons), PhD, Project Engineer, ImpediMed Limited

SOZO with L-Dex for Bilateral Lymphedema | Maree O'Connor, Physiotherapist, Victorian Lymphoedema Practice, Founder Lymphoedema Education Solutions

 

 

Exercise and Cancer Patients: Putting it into Practice

Monday, 13 July 2020 | 7:30 - 8:30PM AEST

Presenters: Brent Collier | Robyn Box

Exercise matters in cancer care. The Clinical Oncology Society of Australia (COSA) states: Clinical research has established exercise as a safe and effective intervention to counteract the adverse physical and psychological effects of cancer and its treatments. Join us to learn more about survivorship and how exercise can make a difference in cancer care.

 

Missed the live webinar? Watch the recorded sessions now by clicking on the linked presentations.

Exercise and Cancer: Putting it into Practice | Robyn Box, MPhty PhD APAM

Exercise and Cancer | Brent Collier, Exercise Physiologist, Director of Peak Health

 

 

Understanding Tissue & Fluid Outputs from SOZO®

Monday, 27 July 2020 | 7:30 - 8:30PM AEST

Presenters: Leigh Ward | Adam Brown | Joanna Jaques

Health is fluid. Explore with us how fluid status and tissue composition analysis can help track healthy patient progress undergoing physical therapy and how SOZO can be an effective tool for monitoring overall health.

 

Missed the live webinar? Watch the recorded sessions now by clicking on the linked presentations.

Understanding Tissue and Fluid Outputs | Dr. Leigh Ward, School of Chemistry and Molecular Biosciences, The University of Queensland

Understanding Tissue and Fluid Outputs | Joanna J Jacques, Accredited Exercise Physiologist

Understanding Tissue and Fluid Outputs | Adam Brown, ImpediMed

 

 

The Future of SOZO®

Monday, 10 August 2020 | 7:30 - 8:30PM AEST

Presenters: Richard Carreon | John Boyages

A single SOZO reading allows clinicians across multiple specialties the ability to provide individualised, proactive care that can help improve patient outcomes. How can SOZO enhance the quality of care you provide to your patients? Join Richard Carreon, Managing Director & CEO of ImpediMed as he shares the future vision of SOZO, and how digitised healthcare is the future of patient care.

 

Missed the live webinar? Watch the recorded sessions now by clicking on the linked presentations.

 

The Future of SOZO | Richard Carreon, President & Chief Executive Officer, ImpediMed

 

Meet our Presenters

Dr. Leigh Ward

Dr. Ward is Honorary Reader in Metabolic and Nutritional Biochemistry at the University of Queensland, Brisbane, Australia having previously been a full-time member of academic staff. Dr. Ward led the development of a leading research groups in the bioimpedance field. This research group were one of the first to apply bioimpedance spectroscopy (BIS) to the study of body composition. This work pioneered the use of BIS for lymphoedema early detection and assessment with a highly cited paper in Lymphology (Early diagnosis of lymphedema using multiple frequency bioimpedance) establishing BIS as the standard for lymphoedema detection.

Catherine Kingsford

Catherine joined ImpediMed in 2007 bringing with her over 20 years of global clinical experience with medical devices. Prior to joining ImpediMed, Catherine worked as a Cardiac Scientist at several world-class medical institutions including St. Andrew’s War Memorial Hospital, The Prince Charles Hospital, and Royal Brompton Hospital. She has studied at Queensland University of Technology (Australia) and University of London (UK).

Joann Yao

Joann is the Senior Director of Marketing for ImpediMed. She has worked in medical device and life science marketing for over ten years with a passion for delivering products and therapies that improve patients’ lives. Her experience includes departmental leadership, strategic planning, new product development, and commercialization. Joann joined ImpediMed in March 2019 and spearheaded development of the Lymphedema Prevention Program with the goal of applying ImpediMed’s technology to end cancer-related lymphedema. She holds a B.S. in Bioengineering from the University of California San Diego and a Masters in Business Administration from the University of California Los Angeles (UCLA) Anderson School of Business.

Jen Mckenzie

Jen McKenzie is a Lymphoedema Physiotherapist and ESSA Accredited Exercise Physiologist. Jen runs her own private allied health clinic, The McKenzie Clinic, on the Sunshine Coast in Queensland, Australia. Jen specialises in treating patients with or following Breast Cancer and those with or at risk of lymphoedema. Jen is passionate about improving referral pathways to Allied Health following a Breast Cancer diagnosis. Jen is Co-Founder of the Breast Cancer Thrivership Program (www.thrivership.com.au) and has set up a Breast Cancer Support Group on the Sunshine Coast.   

Kate Perkins

Kate Perkins is a passionate Cancer Rehabilitation Occupational Therapist (OT), certified Pinc and Steel cancer rehab therapist, Lymphoedema Therapist and founder of Cancer Rehabilitation and Lymphatic Solutions, and the Bounce Back from Breast Cancer Exercise Rehab Program. Kate has helped countless women diagnosed with breast cancer to improve their quality of life and assists recovery through individualised, evidence-based, exercise rehab programs, as well as providing detailed patient education and hands-on treatment. She has a strong focus on the Prospective Surveillance model of practice in the early monitoring for Breast Cancer Related Lymphoedema (BCRL).

Maree O'Conner

Maree is a physiotherapist and established the Victorian Lymphoedema Practice (VLP) in 1992. She has close to 30 years of experience in the area of lymphoedema and also physiotherapy following breast cancer management. She has worked in both the private and public sectors and has always embraced change in lymphoedema management based on evidence-based practice. Her involvement in lymphoedema has not only been from a clinical perspective. She was part of the steering committee that established the Australasian Lymphology Association (ALA) and served as their first president. She has also been on numerous committees and working parties concerning lymphoedema both internationally and nationally at a state and federal level. Maree established Lymphoedema Education Solutions (LES) which delivers lymphoedema courses for health professionals. There are over 1000 health professionals that receive monthly information from LES. She enjoys teaching and making it an authentic learning experience as well as speaking at health professional and public seminars.

Liz Dylke

Dr Elizabeth (Liz) Dylke is a Senior Lecturer in the Discipline of Physiotherapy at the University of Sydney. She completed her undergraduate degree at the University of British Columbia, Canada in Human Kinetics, before undertaking her Masters of Physiotherapy at the University of Sydney. She completed her PhD in 2013, with a focus on the diagnosis of upper limb lymphoedema. Since then, Dr Dylke’s focus has continued to be on understanding and improving the assessment and measurement of lymphoedema, in the upper limb, breast and lower limb.

Louise Koelmeyer

Louise Koelmeyer has over 28 years of clinical experience in both public and private hospital and clinic settings specializing in breast cancer rehabilitation and lymphoedema management in all areas of assessment, education, early detection and treatment. As Lymphoedema Program Manager & Senior Lecturer in the Australian Lymphoedema Education, Research and Treatment (ALERT) program at Macquarie University, Louise is involved in strategically managing and developing the education, research and treatment arms of the innovative multidisciplinary program. Louise’s clinical interests and expertise are in developing a therapeutic relationship with individuals and personalising treatment programs that support the patient’s needs and goals to achieve positive outcomes.

Richelle Gaw

Richelle received a PhD in the field of bioimpedance spectroscopy from Queensland University of Technology and holds a Bachelor of Engineering in Aerospace Avionics with a minor in Systems Engineering from the Queensland University of Technology, Brisbane, Australia. Through her work to study and test device prototypes, Richelle's focus is to support the research community and advance the use of bioimpedance for clinical use.

Brent Collier

Brent Collier has worked as a Health Professional since 1996 in positions ranging from High Performance Sports Science/Coaching, Health Science and Massage Therapy. Brent completed further studies in 2001 when he graduated from University of Wollongong with a degree in Exercise Science and Clinical Rehabilitation. Brent is the Director at Peak Health, one of Sydney’s leading Exercise Physiology and Allied Health Practices. Brent’s unique approach to treatment has helped improve his patients’ outcomes by applying evidence-based rehabilitation to all walks of life.

Joanna Jaques

Joanna is an Accredited Exercise Physiologist with 15 years of clinical experience delivering exercise interventions to patients presenting with a wide range of chronic and complex medical conditions including cardiometabolic, musculoskeletal, neurological and psychological conditions; cancer; and chronic pain. Joanna has worked extensively in university-based, multidisciplinary health clinics and the private sector. She is a sessional lecturer in the Master of Clinical Exercise Physiology program at the Australian Catholic University, and has a keen interest in clinical research. In her role as Exercise Physiologist at MQ Health, Joanna aims to provide her patients with individualised and tailored exercise programs – complementing other medical, dietary and lifestyle interventions - to improve health and wellbeing.

Robyn Box

Robyn graduated from the University of Queensland in 1982 and has over 30 years’ experience working in Cancer care. Having completed her PhD in 2000 investigating the effects of Physiotherapy for Breast Cancer Rehabilitation and Early Detection of Lymphoedema which was initially introduced in 1993, Robyn has worked in public and private health care settings committed to providing individual focused evidence-based best practice to optimize outcomes for patients. Promoting change in patients and health professionals, Robyn has participated in many non-clinical and research activities with education and advisory roles. Robyn has a number of publications, presented at National and International conferences and been a reviewer for a number of journals and research grant bodies. Opening her private practice in 2005 translating her prospective surveillance model into clinical care, Robyn provides physiotherapy rehabilitation and exercise prescription following a cancer diagnosis within individual treatment plans. While lymphoedema awareness, early detection and management are targeted, optimizing health and well-being for patients diagnosed with cancer and/or lymphoedema is integral to the “MOVES for Life” programme offered through the practice.

References:

1.Ridner SH, et al. A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis. Ann Surg Oncol 2019; https://doi.org/10.1245/s10434-019-07344-5

2. Ugur S, et al. Risk factors for breast cancer-related lymphedema. Lymphat Res Biol 2013;11(2):72-5.